Literature DB >> 25469685

Executive Function in Adults With Type 2 Diabetes: A Meta-Analytic Review.

Corita Vincent1, Peter A Hall.   

Abstract

OBJECTIVE: To examine the extent to which Type 2 diabetes mellitus (T2DM) is associated with impairments in executive function (EF).
METHODS: Medline, PsychoInfo, and Scopus databases and published references were used to identify articles examining the association between T2DM status (case versus control) and EF decrements. Results from studies were converted to standardized mean differences and compared using random-effects models. Moderator analysis was conducted for age, sex, and diabetes duration using maximum likelihood estimation.
RESULTS: Sixty studies (59 articles) including 9815 individuals with T2DM and 69,254 controls were included. Findings indicated a small but reliable association between T2DM status and EF decrements (d = -0.248, p < .001), observed across all aspects of EF examined: verbal fluency, mental flexibility, inhibition, working memory, and attention. Disease duration significantly moderated the effect of T2DM status on EF.
CONCLUSIONS: T2DM is associated with a mild-to-moderate EF decrements. Such decrements are stronger among those with shorter disease duration.

Entities:  

Mesh:

Year:  2015        PMID: 25469685     DOI: 10.1097/PSY.0000000000000103

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  28 in total

1.  Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine.

Authors:  Susan A Everson-Rose; John P Ryan
Journal:  Psychosom Med       Date:  2015 Jul-Aug       Impact factor: 4.312

Review 2.  Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.

Authors:  Sebastian Bertram; Klara Brixius; Christian Brinkmann
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

3.  New directions for diabetes prevention and management in behavioral medicine.

Authors:  Barbara Stetson; Karl E Minges; Caroline R Richardson
Journal:  J Behav Med       Date:  2016-10-14

4.  Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology.

Authors:  Josephine Mollon; Joanne E Curran; Samuel R Mathias; Emma E M Knowles; Phoebe Carlisle; Peter T Fox; Rene L Olvera; Harald H H Göring; Amanda Rodrigue; Laura Almasy; Ravi Duggirala; John Blangero; David C Glahn
Journal:  Diabetologia       Date:  2020-02-04       Impact factor: 10.122

5.  Using phenome-wide association studies to examine the effect of environmental exposures on human health.

Authors:  Joseph M Braun; Geetika Kalloo; Samantha L Kingsley; Nan Li
Journal:  Environ Int       Date:  2019-06-11       Impact factor: 9.621

6.  Neural, Hormonal, and Cognitive Correlates of Metabolic Dysfunction and Emotional Reactivity.

Authors:  Tovah Wolf; Vera Tsenkova; Carol D Ryff; Richard J Davidson; Auriel A Willette
Journal:  Psychosom Med       Date:  2018-06       Impact factor: 4.312

7.  Arginine impairs endothelial and executive function in older subjects with cardiovascular risk.

Authors:  Joshua A Beckman; Shelley Hurwitz; Naomi D L Fisher
Journal:  J Am Soc Hypertens       Date:  2018-07-10

8.  Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetes.

Authors:  Sarah E Choi; Bhaswati Roy; Matthew Freeby; Rashmi Mullur; Mary A Woo; Rajesh Kumar
Journal:  J Diabetes       Date:  2020-01-14       Impact factor: 4.006

9.  Metformin/Donepezil combination modulates brain antioxidant status and hippocampal endoplasmic reticulum stress in type 2 diabetic rats.

Authors:  Tajudeen Olabisi Obafemi; Oluwaseun R Olasehinde; Oyindamola A Olaoye; Kikelomo F Jaiyesimi; Funmilayo D Adewumi; Olusola B Adewale; Blessing A Afolabi
Journal:  J Diabetes Metab Disord       Date:  2020-05-16

10.  The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus.

Authors:  Taichi Minami; Yuzuru Ito; Masayo Yamada; Ryutaro Furuta; Fuyuki Minagawa; Kentaro Kamata; Akiko Kameda; Yasuo Terauchi
Journal:  Diabetol Int       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.